224 related articles for article (PubMed ID: 26916311)
1. Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy.
Abu Saadeh F; Langhe R; Galvin DM; O Toole SA; O'Donnell DM; Gleeson N; Norris LA
Thromb Res; 2016 Mar; 139():135-41. PubMed ID: 26916311
[TBL] [Abstract][Full Text] [Related]
2. Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery.
Wright JD; Chen L; Jorge S; Burke WM; Tergas AI; Hou JY; Hu JC; Neugut AI; Ananth CV; Hershman DL
Gynecol Oncol; 2016 Jun; 141(3):531-537. PubMed ID: 27032377
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation post elective caesarean section: effect of low molecular weight heparin.
Ismail SK; Norris L; Muttukrishna S; Higgins JR
Thromb Res; 2012 Nov; 130(5):799-803. PubMed ID: 22365560
[TBL] [Abstract][Full Text] [Related]
4. Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.
D'Alessio A; Marchetti M; Tartari CJ; Russo L; Cecchini S; Lambregts KWFM; di Mauro D; Falanga A
Cancer Invest; 2017 Aug; 35(7):490-499. PubMed ID: 28692314
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
[TBL] [Abstract][Full Text] [Related]
6. Blood coagulation and thrombosis in patients with ovarian malignancy.
von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
[TBL] [Abstract][Full Text] [Related]
7. Lobectomy and postoperative thromboprophylaxis with enoxaparin improve blood hypercoagulability in patients with localized primary lung adenocarcinoma.
Papageorgiou C; Vandreden P; Marret E; Bonnet F; Robert F; Spyropoulos A; Galea V; Elalamy I; Hatmi M; Gerotziafas GT
Thromb Res; 2013 Nov; 132(5):584-91. PubMed ID: 24094602
[TBL] [Abstract][Full Text] [Related]
8. Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
Voils SA; Lemon SJ; Jordan J; Riley P; Frye R
Thromb Res; 2016 Nov; 147():13-15. PubMed ID: 27664391
[TBL] [Abstract][Full Text] [Related]
9. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
10. Bemiparin in oncology.
Monreal Bosch M; Vignoli A; Lecumberri Villamediana R; Prandoni P
Drugs; 2010 Dec; 70 Suppl 2():35-42. PubMed ID: 21162608
[TBL] [Abstract][Full Text] [Related]
11. Padua prediction score and thrombin generation in hospitalized medical patients.
Saliba W; Zahalka W; Goldstein L; Ron G; Elias M
Thromb Res; 2014 Oct; 134(4):803-6. PubMed ID: 25087886
[TBL] [Abstract][Full Text] [Related]
12. The use of inferior vena caval filters prior to major surgery in women with gynaecological cancer.
Adib T; Belli A; McCall J; Ind TE; Bridges JE; Shepherd JH; Barton DP
BJOG; 2008 Jun; 115(7):902-7. PubMed ID: 18485170
[TBL] [Abstract][Full Text] [Related]
13. Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.
Wójcik M; Zaręba L; Undas A
Thromb Res; 2019 Oct; 182():141-149. PubMed ID: 31479942
[TBL] [Abstract][Full Text] [Related]
14. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in advanced ovarian cancer patients undergoing frontline adjuvant chemotherapy.
Pant A; Liu D; Schink J; Lurain J
Int J Gynecol Cancer; 2014 Jul; 24(6):997-1002. PubMed ID: 24905613
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism following gynaecological surgery for suspected or confirmed malignancy.
Hitos K; Wain GV; Fletcher JP
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):23-7. PubMed ID: 21951130
[TBL] [Abstract][Full Text] [Related]
17. High incidence of silent venous thromboembolism before treatment in ovarian cancer.
Satoh T; Oki A; Uno K; Sakurai M; Ochi H; Okada S; Minami R; Matsumoto K; Tanaka YO; Tsunoda H; Homma S; Yoshikawa H
Br J Cancer; 2007 Oct; 97(8):1053-7. PubMed ID: 17895896
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
Orsi FA; Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; van Hylckama Vlieg A; Bos MHA; Leebeek FWG; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2019 Feb; 17(2):319-328. PubMed ID: 30565854
[TBL] [Abstract][Full Text] [Related]
19. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
[TBL] [Abstract][Full Text] [Related]
20. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
